These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32415992)

  • 1. Emerging cardiological issues during the COVID-19 pandemic.
    Everaert BR; Muylle J; Bartholomeus Twickler T
    Eur J Clin Invest; 2020 Jul; 50(7):e13270. PubMed ID: 32415992
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular dysfunction in COVID-19: A diagnostic issue.
    Jacquet-Lagrèze M; Riad Z; Hugon-Vallet E; Ferraris A; Fellahi JL
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):393-394. PubMed ID: 32562808
    [No Abstract]   [Full Text] [Related]  

  • 3. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
    Ogah OS; Umuerri EM; Adebiyi A; Orimolade OA; Sani MU; Ojji DB; Mbakwem AC; Stewart S; Sliwa K
    Glob Heart; 2021 Mar; 16(1):18. PubMed ID: 33833942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same.
    Olry A; Meunier L; Délire B; Larrey D; Horsmans Y; Le Louët H
    Drug Saf; 2020 Jul; 43(7):615-617. PubMed ID: 32514859
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
    Rani S; Grover S; Mehra A; Sahoo S
    Indian J Pharmacol; 2020; 52(3):229-231. PubMed ID: 32874009
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune-Mediated Coagulopathy in COVID-19 Infection.
    Vadasz Z; Brenner B; Toubi E
    Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
    [No Abstract]   [Full Text] [Related]  

  • 8. Current data on the cardiovascular effects of COVID-19.
    Vlachakis PK; Tentolouris A; Tousoulis D; Tentolouris N
    Hellenic J Cardiol; 2020; 61(1):46-48. PubMed ID: 32315757
    [No Abstract]   [Full Text] [Related]  

  • 9. Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemic.
    Capucci A; Santarelli A; Bartolomei M; Paolizzi C; Biagetti C; Dappozzo A; Piovaccari G
    J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):922-923. PubMed ID: 32740441
    [No Abstract]   [Full Text] [Related]  

  • 10. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
    Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
    Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
    [No Abstract]   [Full Text] [Related]  

  • 11. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 12. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Hendren NS; Drazner MH; Bozkurt B; Cooper LT
    Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tako-tsubo syndrome associated with COVID-19.
    Oyarzabal L; Gómez-Hospital JA; Comin-Colet J
    Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):846. PubMed ID: 32763005
    [No Abstract]   [Full Text] [Related]  

  • 14. [COVID-19: a cardiological point-of-view].
    Weckbach LT; Kellnar A; Stremmel C; Stark K; Kääb S
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1063-1067. PubMed ID: 32731280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes.
    Habibzadeh P; Moghadami M; Lankarani KB
    Med Hypotheses; 2020 Oct; 143():109847. PubMed ID: 32460209
    [No Abstract]   [Full Text] [Related]  

  • 16. May IL-17 have a role in COVID-19 infection?
    Megna M; Napolitano M; Fabbrocini G
    Med Hypotheses; 2020 Jul; 140():109749. PubMed ID: 32339777
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.
    Sacher F; Fauchier L; Boveda S; de Chillou C; Defaye P; Deharo JC; Gandjbakhch E; Probst V; Cohen A; Leclercq C;
    Arch Cardiovasc Dis; 2020 May; 113(5):293-296. PubMed ID: 32354666
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
    Monte Serrano J; Cruañes Monferrer J; García-García M; García-Gil MF
    Med Clin (Barc); 2020 Sep; 155(5):231. PubMed ID: 32522372
    [No Abstract]   [Full Text] [Related]  

  • 19. Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin.
    Chang D; Saleh M; Gabriels J; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Epstein LM
    J Am Coll Cardiol; 2020 Jun; 75(23):2992-2993. PubMed ID: 32330546
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.